Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Do

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|February 12, 2026
FOXF2 regulates pericyte-endothelial signaling required for vascular homeostasis after neonatal hyperoxic lung injuryFei Sun, Yuchen Zhao, Jonathan Do, et al.
Vaccine|August 24, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|June 29, 2026
Emergence of fibrotic pericytes and their transcriptional regulation in pulmonary fibrosisWen Gao, Ying-Wei Lan, Zicheng Deng, et al.
Nature Communications|May 18, 2025
A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioningSoohyun Kim, Caelan E Radford, Duo Xu, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|April 17, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|October 5, 2023
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|February 12, 2026
FOXF2 regulates pericyte-endothelial signaling required for vascular homeostasis after neonatal hyperoxic lung injuryFei Sun, Yuchen Zhao, Jonathan Do, et al.
Vaccine|August 24, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|June 29, 2026
Emergence of fibrotic pericytes and their transcriptional regulation in pulmonary fibrosisWen Gao, Ying-Wei Lan, Zicheng Deng, et al.
Nature Communications|May 18, 2025
A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioningSoohyun Kim, Caelan E Radford, Duo Xu, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|April 17, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|October 5, 2023
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Pageof 2